Biocon gets over Rs 3 crore penalty over GST related issues

Biocon said it is "in the process of taking appropriate actions, including but not limited to, filing of the necessary appeal with the appellate authority in this regard". There is no material impact on the financials, operations or other activities of the company, the filing said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news